Figure 1. Best tumor response for each evaluable patient.
The two patients with known BRCA2 mutations are noted. Several patients developed progressive disease because of progression in non-target lesions or the development of new lesions.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.